- Filed
- Jun 6, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding restated | Q3 2024 · May 10, 2024 | 120.16M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2024 | 92.93M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2024 | 90.66M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 85.73M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 82.36M sh |
| Capex | Q3 2024 · Mar 31, 2024 | $272.78K |
| Capex | Q3 2024 · Mar 31, 2023 | $511.52K |
| Operating Cash Flow | Q3 2024 · Mar 31, 2024 | −$5.66M |
| Operating Cash Flow | Q3 2024 · Mar 31, 2023 | −$10.07M |
| Cash And Equivalents | Q3 2024 · Mar 31, 2024 | $533.6K |
| Cash And Equivalents | Q3 2024 · Jun 30, 2023 | $812.81K |
| Cash And Equivalents | Q3 2024 · Jun 30, 2022 | $772.06K |
| Stockholders Equity restated | Q3 2024 · Mar 31, 2024 | $2.4M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $4.11M |
| Current Liabilities restated | Q3 2024 · Mar 31, 2024 | $10.6M |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $10.02M |
| Total Liabilities restated | Q3 2024 · Mar 31, 2024 | $21.39M |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $20.92M |
| Current Assets restated | Q3 2024 · Mar 31, 2024 | $9.56M |
| Current Assets | Q3 2024 · Jun 30, 2023 | $9.82M |
| Total Assets restated | Q3 2024 · Mar 31, 2024 | $23.85M |
| Total Assets | Q3 2024 · Jun 30, 2023 | $25.17M |
| Eps Diluted restated | Q3 2024 · Mar 31, 2024 | −$0.10 |
| Eps Diluted restated | Q3 2024 · Mar 31, 2024 | −$0.21 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$0.05 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$0.15 |
| Eps Basic restated | Q3 2024 · Mar 31, 2024 | −$0.10 |
| Eps Basic restated | Q3 2024 · Mar 31, 2024 | −$0.21 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | −$0.05 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | −$0.15 |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $7M |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $19.27M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $6.5M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $18.44M |
| Net Income restated | Q3 2024 · Mar 31, 2024 | −$9.25M |
| Net Income restated | Q3 2024 · Mar 31, 2024 | −$19.47M |
| Net Income | Q3 2024 · Mar 31, 2023 | −$4.03M |
| Net Income | Q3 2024 · Mar 31, 2023 | −$12.06M |
| Operating Income restated | Q3 2024 · Mar 31, 2024 | −$8.65M |
| Operating Income restated | Q3 2024 · Mar 31, 2024 | −$17.95M |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$3.64M |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$11.38M |
| Gross Profit restated | Q3 2024 · Mar 31, 2024 | −$1.65M |
| Gross Profit restated | Q3 2024 · Mar 31, 2024 | $1.32M |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $2.86M |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $7.06M |
| Cost Of Revenue restated | Q3 2024 · Mar 31, 2024 | $5.08M |
| Cost Of Revenue restated | Q3 2024 · Mar 31, 2024 | $13.21M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $6.61M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $11.92M |
| Revenue restated | Q3 2024 · Mar 31, 2024 | $3.43M |
| Revenue restated | Q3 2024 · Mar 31, 2024 | $14.52M |
| Revenue | Q3 2024 · Mar 31, 2023 | $9.47M |
| Revenue | Q3 2024 · Mar 31, 2023 | $18.99M |